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Activity of meropenem, against Gram-positive bacteria
F. H. Kayser, G. Morenzoni, A. Strassle and K. Hadorn
Institute of Medical Microbiology. University of Zurich, CH-8028 Zurich, Switzerland
A new carbapenem antibiotic, meropenem, was shown to be active against a large
number of Gram-positive bacteria. The drug inhibited penicillinase-positive and
-negative, methicillin-susceptible staphylococti equally well. Among the comparative
antimicrobials examined, only Af-formimidoyl-thienamycin (imipenem) was two to
four times more active than meropenem. Compared with vancomycin or methicillin,
meropenem was 10-20 times more active. Strains of 11 species of streptococci were
highly susceptible to meropenem; the geometric mean MICs of the drug for these
species ranged from 0-01 to 0-04 mg/1. The agent, however, only had moderate
activity against Enterococcus faecalis (mean MIC 5 mg/1) and Ent.faecium (mean
MIC 11-6 mg/1). Among Corynebacterium jeikeium, strains were encountered that
showed susceptibility to meropenem but resistance to imipenem and other /J-
lactams. Strains of other corynebacteria, Rhodococcus equi, Erysopelothrix rhusio-
pathiae, Listeria monocytogenes, and Bacillus spp. all were highly susceptible to
meropenem (mean MICs 0-04-0-17 mg/1). Although methicillin-resistant staphylo-
cocci were inhibited by concentrations of 1-2 mg/1 of meropenem in agar dilution
tests, such strains showed heteroresistance in population studies, as is typical for all
/J-lactam antibiotics. In addition, the biochemical correlate of methicillin-resistance,
penicillin-binding protein 2', showed low affinity for meropenem, similar to that for
imipenem. Meropenem was as bactericidal as imipenem and comparative bacteri-
cidal antimicrobials in killing-curve experiments. Strains of Ent.faecium, C. jeikeium,
and L. monocytogenes were killed at a slower rate than streptococci or staphylococci.
Introduction
This study was undertaken to compare the in-vitro activity of meropenem with those of
imipenem and various other antimicrobials against Gram-positive organisms. Special
emphasis in our study was given to the bactericidal activity of meropenem, which was
determined in killing-curve experiments.
Materials and methods
Bacteria
The bacteria used were isolated from clinical material and were identified according to
standard procedures. Unusual organisms of no or only low pathogenic potential were
included in order to obtain an overview of the Gram-positive spectrum of the drug. The
strains Staphylococcus aureus ATCC 29213, Escherichia coli ATCC 25922, and Pseudo-
monas aeruginosa ATCC 27853 were used for quality control.
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Antibiotics
Stock solutions of mcropcnem and ciprofloxadn were prepared in sterile distilled .water.
Stock solutions of the other drugs were prepared as recommended by the NCCLS
(1987). Stocks of meropcnem and imipenem were freshly prepared for each experiment.
The other stock solutions were stored at — 80°C. All drugs were kindly provided as
laboratory powders by the respective pharmaceutical companies.
Minimal inhibitory concentration tests
MICs were determined by an agar dilution procedure (NCCLS, 1985, 1987) with
Mueller-Hinton (MH) agar (BBL) for staphylococci and Mueller-Hinton agar supple-
mented with 7% human blood for all other organisms. Staphylococci were tested on
Mueller-Hinton agar as well as on Mueller-Hinton agar supplemented with 4% NaCl
(Jorgensen, 1986) in order to detect methicillin-resistance. MICs of methicillin were
read after incubation at 35°C for exactly 24 h. Methicillin-resistance was suggested
when growth was observed on the plate containing 8 mg/1. MICs of the other /Mactam
antibiotics were then compared in order to make a final decision about the presence of
methicillin-resistance.
Bactericidal tests
Selected staphylococcal strains grown on blood agar were suspended in MH broth to
approximately 10*-107 cfu/ml. All other organisms were taken from blood agar and
suspended in MH broth supplemented with cations and 2-5% lysed horse blood
(NCCLS, 1987). Antibiotics were added in concentrations of }, 1, 2, 4 and 8 times the
MIC, respectively. One culture served as growth control. Incubation was carried out at
37°C in a water bath. At appropriate time intervals, samples were withdrawn and
plated undiluted or in appropriate dilutions on to blood agar plates to determine the
viable count. When necessary, /Mactam antibiotics in samples were inactivated by
adding 12-5 U/ml of a mixture of four penicillinases (Porton Products Ltd, Salisbury,
Wiltshire, UK), and incubating the samples at room temperature for at least lOmin
before plating. Inactivation of /Mactams including the carbapenems was confirmed by a
qualitative disc diffusion test.
Population studies
Populations of methicillin-resistant and -susceptible staphylococci were analysed by
disaggregation of overnight broth cultures (briefly, by ultrasonication at 20 kHz) and
surface inoculation of appropriate dilutions on L-agar (Berger-Bachi, Strassle &
Kayser, 1986) containing increasing amounts of meropenem. Colony-forming units
were counted after 48 h of incubation at 35°C.
Penicillin-binding proteins
Amnity of ^-lactam antibiotics for penicillin-binding proteins (PBPs) prepared from
cell membranes was examined in competition assays with radioactive benzylpenicillin,
by a procedure slightly modified from that described recently by Berger-Bachi et al.
(1986). Membrane preparations were incubated for lOmin at 37°C in the presence of 0,
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0-5, 5, 50 and 500mg/l of either meropenem or imipenem before reaction with 10mg/l
3[H]-labelled benzylpenicillin-ethyl-piperidinium salt (25Ci/mmol, Merck, USA) for
lOmin at 37°C. 50 n% protein was loaded per slot PBPs were separated by SDS
polyacrylamide gel electrophoresis. The acrylamide to NN' methylene iir-acrylamide
ratio was 3-75-0-1% in the stacking gel and 10-0-13% in the running gel. PBPs were
detected by scintillation fluorography with NEN enhancer (New England Nuclear,
USA) and exposing the gels at -70°C to Fuji RX1 film.
Results
Comparison of meropenem with other antimicrobials against Gram-positive bacteria
Table I summarizes the MICs of meropenem and other drugs for Gram-positive
bacteria. Meropenem showed excellent activity against methicillin-susceptiblc staphylo-
cocci, whether they produced penicillinase or not. The drug was 12-14 times more
active than methicillin. Imipenem was three to five times more active than meropenem
against these strains. All of the eleven streptococcal species tested were highly suscept-
ible to meropenem and to imipenem. Both drugs, however, exhibited only moderate
activity against Enterococcus faecalis, and were of rather low activity against Ent.fae-
cium.
Corynebacterium jeikeium has been associated with infections in immunosuppressed
patients (Young et al., 1981). The organism has also been isolated occasionally from
cases of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis
(Pierard et al., 1983). Often, these bacteria have been found to be resistant to many
antimicrobials including the aminoglycosides and /Mactam antibiotics (Gill et al.,
1981). This situation has been found also with the collection of strains examined in this
study. However, some strains that were highly resistant to imipenem (MICs >
128mg/l) were susceptible to meropenem (MICs 2-8mg/l). Other corynebacteria
generally were highly susceptible to both carbapenems. Highly susceptible, also, were
the Hsteria monocytogenes strains examined. MICs of meropenem for the NCCLS
quality control strains determined in agar dilution tests were the same on either
Mueller-Hinton agar or Mueller-Hinton agar supplemented with 7% human blood.
The range of MICs for Staph. aureus ATCC29213 was 0-06-0-12 mg/1, that for
Esch. coli ATCC 25922 0-016-0-03, and that for P. aeruginosa 0-25-1 mg/1.
Results with methicillin-resistant staphylococci
Meropenem and imipenem showed some activity against methicillin-resistant staphylo-
cocci, when tested in agar dilution with an inoculum of 10* cfu per spot (see Table I). In
tests with a higher inoculum, i.e. in macrobroth dilution tests, MICs of these carbape-
nems were considerably higher (data not shown). This phenomenon resulted from the
heterogeneous resistance to /Mactam antibiotics in such strains (Kayser et al., 1972).
Figure 1 shows the population analysis of four isogenic Staph. aureus strains on
meropenem. Strain BB255 was the susceptible parent strain. Strain BB270 was
obtained by introducing the methicillin resistance determinant mec from a wild type
strain into BB255. Two main resistance levels were recognizable: a low basal level,
displayed by all cells, and a second higher, but heterogeneous, level shown here by one
in 103 cells. The phenotypically susceptible strain BB308, derived from strain BB270 by
To557-insertion of (12003 into the chromosome, although harbouring the intact
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Figure 1. Population analysis of four isogenic Staph. aureus strains on meropenem. D . Methicillin-
susceptible strain BB25S; • , methicillin-resistant strain BB27O, A , methicillin-susceptible strain BB3O8
derived from BB270 by TnJ5/ insertion; O, methicillin-resistant revertant strain r2 derived from BB3O8, with
a deletion within the chromosome.
methicillin resistance determinant mec, had lost the expression of low level resistance
and the high level resistance was impaired. Strain r2 was a revertant from BB308 with a
deletion within the chromosome. This strain had regained both resistance levels and
showed a resistance pattern similar to BB270. (For a more detailed description of the
strains see Berger-Bachi et al., 1986.) The patterns shown in Figure 1 are very similar
to results of population studies with imipenem (Berger-Bachi et al., 1986). Heteroresis-
tance to meropenem was also observed in strains of coagulase-negative staphylococci
harbouring the mec-determinant (data not shown). The results obtained by measuring
the affinity of meropenem and imipenem to the PBPs of Staph. aureus were in
accordance with the population studies (Figure 2). Whereas PBPs of the susceptible
strain BB2SS were saturated by low amounts of the antibiotics (Figure 2(a)), high
amounts were necessary to saturate PBP 2', the biochemical correlate of methicillin-
resistance, in strain BB270 (see Figure 2(b)).
Bactericidal activity of meropenem
Examination of the bactericidal activity of meropenem and comparative agents initially
was carried out by conventional MBC tests performed in triplicate. Although great care
was taken in performing these tests, results were often inconsistent, especially with
staphylococci, owing to methodological problems (see Taylor et al., 1983). We there-
fore decided to study the bactericidal potential of the drug in a kinetic system. Figure 3
shows the killing curves obtained with meropenem at various multiples of the MIC
against three representative strains (one each of Staph. aureus, Streptococcus agalactiae
and Enterococcus faecalis). The drug killed efficiently, even at rather low concentra-
tions. The rate and the degree of killing of the Staph. aureus was less pronounced at
four and eight times than at one and two times the MIC (Figure 3(a)). This well-known
paradoxical effect was also observed with imipenem and flucloxacillin (data not
shown). Not all the staphylococcal strains examined, however, exhibited this beha-
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Figure 2. Fluorograph of penicillin binding proteins of (a) methicillin-susceptible Staph. aureus BB2SS and
(b) methicillin-resistant strain BB27O. Membrane preparations were prepared as described and preincubated
with various concentrations of either meropenem or imipenem, before treatment with 3H-labelled penicillin.
Lanes: a, 0; b, 0-5; c, 5; d, 50; and e, 500 mg/1 of either meropenem or imipenem, respectively.
viour. Figure 4 shows the killing curves of meropenem in comparison with imipenem
and further bactericidal antimicrobials at four times the MIC of each antibiotic for
Ent.faecium, C.jeikeium, and L.monocytogenes. The bactericidal activities of the /?-
lactam antibiotics tested were approximately equal. The rate of killing of meropenem
and comparative drugs for all species was low during 6 h of incubation, but increased
by incubating for 24 h.
24 0 24
Time (h)
Figure 3. Rates of killing of (a) penicillinase-producing Staph. aureus (MIC of meropenem 0-25 mg/1); (b)
Enl.faecalis (MIC 4 mg/1); (c) Sir. agalacliae (MIC 0-016 mg/1), by various concentration of meropenem. O.
Control; • , ixMIC; • , lxMIC, O. 2xMIC; • , 4xMlC; D, 8xMlC.
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Figure 4. Comparison of the rate of killing of Gram-positive organisms by 4 times the MIC of • ,
meropenem; 0 , imipenem; O, various bactericidal antimicrobials. O, Growth control, (a) Penkillinase-
negative Slaph. aureus (MIC of meropenem 006; imipenem 0008; fludoxacillin (O) 025 mg/1). (b) Staph.
epidermidis (MIC of meropenem 012; imipenem 003; vancomycin (O) 2mg/l). (c) Ent.faecium (MIC of
meropenem 4; imipenem 1; vancomycin (O) 4mg/l). (d) Strtp.pyogenes (MIC of meropenem 0016;
imipenem 0004; benzylpenicillin (O) 0016 mg/1. (e) C.Jeikeium (MIC of meropenem 2; imipenem 8;
vancomycin (O) 1 mg/1). (0 L. numocyiogenes (MIC of meropenem 006; imipenem 006; ampkillin (O)
025 mg/1).
Discussion
Meropenem was shown to be an excellent antibiotic against most species of Gram-
positive bacteria. In particular, the drug exhibited some activity against methicillin-
resistant staphylococci, when tested in agar dilution with an inoculum of 10*cru per
spot. However, the typical characteristics of methicillin-resistant staphylococci, namely
heteroresistance (Figure 1), and the influence of incubation temperature, duration of
incubation, and sodium chloride content of the agar medium on the phenotypic
expression of resistance (data not shown), were also observed with meropenem (data
not shown). Thus, as with all other /Mactam antibiotics (Kayser, 1980), meropenem
does not seem likely to be a useful agent in the treatment of diseases caused by
methicillin-resistant staphylococci. Meropenem exhibited high activity against all strep-
tococcal species examined. Against Enterococcus faecalis, meropenem was approxi-
mately four times less active than imipenem, but showed similar activity to piperacillin,
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whereas, as expected, the cephalosporins were not active at all. Meropenem was as
bactericidal as other /Mactam agents against most of the examined organisms in kinetic
studies. Only poor bactericidal activity of the /Mactams was observed against Ent.fae-
cium, C.jeikeium and L. monocytogenes.
In summary, this new experimental carbapenem antibiotic exhibited nearly identical
properties to imipenem against Gram-positive organisms. Its greater stability to the
dehydropeptidase-1 enzyme of the human kidney and its superior activity against
Gram-negative organisms, including Pseudomonas spp., justify clinical trials.
References
Berger-Bachi, B., Strassle, A., & Kayser, F. H. (1986). Characterization of an isogenic set of
methicillin-resistant and susceptible mutants of Staphylococcus aureus. European Journal of
Clinical Microbiology 5, 697-701.
Gill, V. J., Manning, C , Lamson, M., Woltering, P. & Pizzo, P. A. (1981). Antibiotic-resistant
group JK bacteria in hospitals. Journal of Clinical Microbiology 13, 472-7.
Jorgensen, J. H. (1986). Laboratory and epidemiologic experience with methicillin-resistant
Staphylococcus aureus in the USA. European Journal of Clinical Microbiology 5, 693-6.
Kayser, F. H. (1980). Die Resistenz methicillinresistenter Staphylokokken gegenuber neuen
Cephalosporin-Antibiotika. Infection 8, 165-70.
Kayser, F. H., Benner, E. J., Troy, R. & Hoeprich, P. D. (1972). Mode of resistance against 0-
lactam antibiotics in staphylococci. Annals of the New York Academy of Sciences 182, 106—
17.
National Committee for Clinical Laboratory Standards (NCCLS) (1985). Methods for dilution
antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-
A. The National Committee for Clinical Laboratory Standards, Vol. 5, No. 22.
National Committee for Clinical Laboratory Standards (NCCLS) (1987). Performance standards
for antimicrobial susceptibility testing. First informational Supplement M7-A-S2. The
National Committee for Clinical Laboratory Standards, Vol. 7, No. 10.
Pierard, D., Lauwers, S., Mouton, M. Sennesael, J. & Verbeelen, D. (1983). Group JK
corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal
dialysis. Journal of Clinical Microbiology 18, 1011-4.
Taylor, P. C, Schoenknecht, F. D., Sherris, J. C. & Linner, E. C. (1983). Determination of
minimum bactericidal concentration of oxacillin for Staphylococcus aureus: influence and
significance of technical factors. Antimicrobial Agents and Chemotherapy 23, 142-50.
Young, V. M., Meyers, W. F., Moody, M. R. & Schimpff, S. C. (1981). The emergence of
coryneform bacteria as a cause of nosocomial infection in compromised hosts. American
Journal of Medicine 70, 646-50.
